EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Three‐Step Diagnostic Strategy for Malignant Pleural Effusions

Elisa Nuez-Zaragoza iD, Vicente Aguadero iD, Indira Bhambi-Blanco iD, Mònica Vidal-Pla iD, Isabel Aparicio-Calvente iD, M Rosa Escoda-Giralt, Joana Gallardo-Campos, Joan Carles Ferreres iD, Luis Frisancho iD, Laia Mas-Maresma iD, Patricia Aguilera-Fernández, Sonia Marco-Continente iD und 6 weitere

Cancer Medicine · 2026-06 · 15 (6)

DOI: 10.1002/cam4.71955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 16.06.2026. Verfasst von Elisa Nuez-Zaragoza und 17 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma d…. Hauptthemen laut MEDLINE: Pleural Effusion, Malignant, Biomarkers, Tumor. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Parc Taulí Research and Innovation Institute (I3PT), Fundación Jose Luis Castaño (SEQC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New diagnostic tools, such as high fluorescence cells (HFc) and tumor markers (TMs), have emerged in the quest to accurately diagnose malignant pleural effusion (MPE). This study evaluated the diagnostic performance of the HFc and TMs combination. Hospitalized patients with pleural effusion were recruited at Parc Taulí University Hospital in Sabadell (Spain). Pleural fluid (PF) and serum samples were collected and analyzed in the Clinical Laboratory, and PF samples were sent to the Pathology Department for cytological examination. PF cell counts were determined using an XN‐10 analyzer (Sysmex, Kobe, Japan); TMs (CEA, CA 19.9, CA 15.3, CA 72.4, and CYFRA 21.1) were assessed using Cobas e801 (Roche Diagnostics, Mannheim, Germany). An MPE diagnosis was made based on positive cytology and/or positive pleural biopsy. A diagnostic algorithm was developed to detect MPE starting with an initial HFc screening, followed by TM determination with specific cutoffs depending on fluid type. The study included 300 pleural effusions from 209 patients. The algorithm had a sensitivity of 68% and a negative predictive value of 93%; its specificity and positive predictive value were both 100%. When combined with cytology, the sensitivity of the algorithm increased to 85%, and its negative predictive value to 96%. Our algorithm exhibited promising diagnostic performance and could serve as a non‐invasive tool for MPE detection. HFc screening helps identify potential MPE cases, and TM assessment, with its high specificity, contributes to MPE confirmation. Furthermore, establishing different TM cutoffs based on fluid type increases sensitivity without reducing specificity by introducing false positives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pleural Effusion, MalignantBiomarkers, TumorHumansFemaleMaleAgedMiddle AgedAlgorithmsSensitivity and SpecificityAged, 80 and overAdult

Stichwörter der Autor:innen

high fluorescence cellsmalignant pleural effusiontumor markers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Clinical Laboratory Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
  • Laboratory Department, CLILAB, Sant Joan Despí-Moisès Broggi Hospital, Sant Joan Despí, Spain.
  • Pathology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
  • Digestive System Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
  • Internal Medicine Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.
  • Intensive Care Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain.

ORCID-Profile: Elisa Nuez-Zaragoza, Vicente Aguadero, Indira Bhambi-Blanco, Mònica Vidal-Pla, Isabel Aparicio-Calvente, Joan Carles Ferreres, Luis Frisancho, Laia Mas-Maresma, Sonia Marco-Continente, Marina Sierra-Boada, Pablo Andreu-Cobo, Miquel Gallego, Javier Hernando-Redondo, Jaume Trapé

Förderung

  • Parc Taulí Research and Innovation Institute (I3PT)
  • Fundación Jose Luis Castaño (SEQC)

Zitieren

APA

Nuez-Zaragoza, E., Aguadero, V., Bhambi-Blanco, I., Vidal-Pla, M., Aparicio-Calvente, I., Escoda-Giralt, M. R., Gallardo-Campos, J., Ferreres, J. C., Frisancho, L., Mas-Maresma, L., Aguilera-Fernández, P., Marco-Continente, S., Sierra-Boada, M., Andreu-Cobo, P., Gallego, M., Canalias, F., Hernando-Redondo, J., & Trapé, J. (2026). A Three‐Step Diagnostic Strategy for Malignant Pleural Effusions. Cancer Medicine, 15(6). https://doi.org/10.1002/cam4.71955

Vancouver

Nuez-Zaragoza E, Aguadero V, Bhambi-Blanco I, Vidal-Pla M, Aparicio-Calvente I, Escoda-Giralt MR, et al. A Three‐Step Diagnostic Strategy for Malignant Pleural Effusions. Cancer Medicine. 2026;15(6). doi:10.1002/cam4.71955

BibTeX
@article{NuezZaragoza2026,
  author = {Nuez-Zaragoza, Elisa and Aguadero, Vicente and Bhambi-Blanco, Indira and Vidal-Pla, Mònica and Aparicio-Calvente, Isabel and Escoda-Giralt, M Rosa and Gallardo-Campos, Joana and Ferreres, Joan Carles and Frisancho, Luis and Mas-Maresma, Laia and Aguilera-Fernández, Patricia and Marco-Continente, Sonia and Sierra-Boada, Marina and Andreu-Cobo, Pablo and Gallego, Miquel and Canalias, Francesca and Hernando-Redondo, Javier and Trapé, Jaume},
  title = {A Three‐Step Diagnostic Strategy for Malignant Pleural Effusions},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  doi = {10.1002/cam4.71955}
}
Kostenlos starten →